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Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489S412high sensitive C-reactive protein (hsCRP), matrix metalloproteinase
(MMP) mediated degradation of CRP (CRPM) and MMP-mediated col-
lagen type I, II, and III degradation (C1M, C2M, and C3M, respectively).
Statistical analyses were performed in IBM SPSS Statistics, version 19.
One-way ANOVA was used to compare serological biomarkers and PPT
measures and Fisher’s Least Signiﬁcant Difference (LSD) post hoc test
was applied.
Results: Group B (BLOKS ¼ 2,3) had decreased PPTs compared to con-
trols (p< 0.05, ﬁgure 1) and increased levels of C1M (p¼ 0.001), C2M (p
¼ 0.001) and hsCRP (p ¼ 0.023), but a lower level of C3M (p ¼ 0.033)
compared to controls (Figure 2). Group A had increased levels of C1M (p
¼ 0.039), C2M (p¼ 0.001) and CRPM (p¼ 0.028) and lower level of C3M
(p ¼ 0.019), but no difference was found in PPTs compared to controls.
Dividing Group A into BLOKS ¼ 0, (n ¼ 16) and BLOKS ¼ 1 (n ¼ 22)
revealed that patients with BLOKS ¼ 0 had decreased PPTs compared to
patients with BLOKS ¼ 1 (p < 0.05, Figure 1). Interestingly, the level of
PPTs of the BLOKS¼ 0 group was at the level of the group with BLOKS
2. There was no signiﬁcant difference in the biomarker level in the
differentiated Group A in any of the investigated markers (Figure 2).
Conclusions: Patients with widespread synovitis have decreased PPTs
and signiﬁcantly increased levels of bone and cartilage degradation and
inﬂammation. However, these patients had a decrease in synovial
membrane degradation compared to controls. Dividing patients with
localized synovitis into two groups based on the synovitis score iden-
tiﬁed subgroups with signiﬁcantly different PPTs, but the same level of
the biomarkers studied. This study illustrate that patients with different
levels of sensitization have different proﬁles of tissue turnover and each
constitute a speciﬁc group of severe KOA patients.
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A CLINICAL TOOL FOR THE PREDICTION OF PATIENT-REPORTED
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Southampton Gen. Hosp., Southampton, United KingdomPurpose: To develop a clinical risk prediction tool to predict patient-
reported outcomes after undergoing primary total knee replacement
(TKR) surgery.
Methods:We used data from 1,649 patients from the Knee Arthroplasty
Trial (KAT) who received primary TKR across 34 centres in the United
Kingdom between July 1999 and January 2003. The main outcome was
Oxford Knee Score (OKS) 12-months after surgery. A wide range of pre-
operative predictor variables including patient characteristics, clinical
and surgical factors, were considered. Bootstrap backward linear
regression analysis was used to identify risk factors of outcome.
Results: Presence of a ﬁxed ﬂexion deformity, presence of varus/valgus
deformity (compared with no deformity), and an absent preoperative
ACL (compared with intact ACL) were associated with better OKS at 12
months. The clinical factors associated with worse post-operative OKS
were worse ASA grade, presence of other conditions affecting mobility
and previous knee surgery. Lower pre-operative OKS, living in poor
areas, high BMI and worse SF-12 mental health score were also asso-
ciated with worse outcome. Discrimination and calibration statistics
were good. Patients’ characteristics explained 16.6% of the variability in
outcome, when clinical variables were included 18.9% of the variance of
outcome was explained, reaching 20.2% when surgical variables were
added.
Conclusions: The clinical risk tool will help to inform patients and
clinicians regarding expectations of the outcome after knee replace-
ment surgery, and may also provide useful information to support
shared decision-making. External validation of the tool, to conﬁrm its
performance and validity, will be undertaken in a new prospective
cohort of patients.
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Purpose: It has been recently demonstrated the association between
pain and depression in patients with knee osteoarthritis (OA). Although
knee OA is a slowly but progressive disease, the severity of pain is not
always increased dependent upon the radiographic severity of the
disease in patients with knee OA. It is speculated that the psychological
state, such as depression, may affect the severity of pain in patients with
knee OA. As all the treatment methods currently available are symp-
tom-modifying treatments, it is important to understand the psycho-
logical state of the patients with knee OA. Depression is one of themajor
complications in patients with inﬂammatory diseases, and is suggested
to affect the activity of the disease. Inﬂammatory disease-induced
depression, or so-called “sickness behavior,” is speculated to be induced
by inﬂammatory cytokines, such as interleukin (IL)-6 and IL-1, which
are increased by the disease. The severity of depression is associated
with serum levels of C-reactive protein (CRP) in patients with rheu-
matoid arthritis (RA). In contrast to these inﬂammatory diseases, few
studies have been conduced to investigate the relationship between the
severity of depression and the serum levels of inﬂammatory cytokines
in patients with knee OA.
The aim of this cross sectional study was to investigate whether there
was any relationship between serum levels of IL-6 and the self-rated
depression scale in patients with knee OA.
Methods: Between July, 2011 and November, 2012, one-hundred ﬁfteen
postmenopausal women with painful knee OA who provided written
informed consent were enrolled. The severity of knee OA was classiﬁed
by Kellgren–Lawrence (K/L) grading scale based on standing extended-
knee X-ray images. All patients had knee OA with K/L grade 2 or more.
Serum levels of IL-6 and hs-CRP were measured to monitor the severity
of inﬂammation in patients with knee OA. The Zung’s self-rating
depression scale (SDS) was used to measure the severity of depression.
Pain was evaluated by a visual analogue scale (VAS, 0–100). Pain and
stiffness sub-category of Japanese Knee Osteoarthritis Measure (JKOM-
